Amour, Augustin, Knight, C. Graham, English, William R., Webster, Ailsa, Slocombe, Patrick M., Knauper, Vera ![]() |
Abstract
The ADAM family of proteases are type I transmembrane proteins with both metalloproteinase and disintegrin containing extracellular domains. ADAMs are implicated in the proteolytic processing of membrane-bound precursors and involved in modulating cell–cell and cell–matrix interactions. ADAM8 (MS2, CD156) has been identified in myeloid and B cells. In this report we demonstrate that soluble ADAM8 is an active metalloprotease in vitro and is able to hydrolyse myelin basic protein and a variety of peptide substrates based on the cleavage sites of membrane-bound cytokines, growth factors and receptors which are known to be processed by metalloproteinases. Interestingly, although ADAM8 was inhibited by a number of peptide analogue hydroxamate inhibitors, it was not inhibited by the tissue inhibitors of metalloproteinases (TIMPs). We also demonstrate that the activity of recombinant soluble ADAM9 (meltrin-γ, MDC9) lacks inhibition by the TIMPs, but can be inhibited by hydroxamate inhibitors. The lack of TIMP inhibition of ADAM8 and 9 contrasts with other membrane-associated metalloproteinases characterised to date in this respect (ADAM10, 12, 17, and the membrane-type metalloproteinases) which have been implicated in protein processing at the cell surface.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Dentistry |
Subjects: | Q Science > Q Science (General) |
Uncontrolled Keywords: | Metalloproteinase, Disintegrin metalloproteinase, ADAM, Tissue inhibitor of metalloproteinases, Membrane-type metalloproteinase. |
Publisher: | Elsevier |
ISSN: | 0014-5793 |
Last Modified: | 27 Oct 2022 10:13 |
URI: | https://orca.cardiff.ac.uk/id/eprint/69339 |
Citation Data
Cited 134 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]() |
Edit Item |